News
A new monograph “Centella asiatica: entering a new era”, dedicated to Centella asiatica, has been recently published by Indena with the aim of crossing new boundaries of this important medicinal plant.
A new monograph “Centella asiatica: entering a new era”, dedicated to Centella asiatica, has been recently published by Indena with the aim of crossing new boundaries of this important medicinal plant, widely used both in Indian Ayurvedic medicine and as a traditional medicine.
Centella asiatica, also known as “gotu kola”, is native to the wetlands of Southeast Asia and belongs to the Apiaceae family; it has been used for centuries in traditional medicine because of its anti-bacterial, anti-viral, anti-hypertensive, diuretic, antiulcer and anti-inflammatory properties. The most known active compounds are asiaticoside, madecassoside, asiatic acid and madecassic acid which promote the synthesis of collagen, regulate inflammation by normalizing the hyperproliferation of keratinocytes and are able to restore the natural homeostasis of the epidermis.The monograph “Centella asiatica: entering a new era” highlights that the pre-clinical and clinical studies available, while confirming the already known properties of the plant and its traditional uses, envisages new research scenarios and broader applications, from diabetic neuropathy to cardiovascular protection, from the treatment of burns to post-partum stretch marks. These areas could open new frontiers of research and development on a plant and its properties which have been known for centuries but whose potential has still more to offer.A first important new evidence is in the cardiovascular field, where the healing properties of Centella asiatica have inspired a new concept: the extract, similarly to the modulation of keloids on skin has been proven effective on atherosclerotic plaques as well – it was shown to prevent thrombotic or embolic complications by increasing the density and stability of atherosclerotic echolucent plaques in patients with atherosclerosis.Another field where Centella asiatica may qualify for broader applications is neurology: the plant’s effectiveness for the preservation of memory and cognitive functions is already known, since it is able to prevent neuronal degeneration, especially beta-amyloid. In addition, Centella asiatica appears to have a neuroprotective effect on stroke-induced cognitive impairment and in Parkinson’s disease. Moreover, Centella asiatica is now a potential candidate for the treatment of the reduction of neurological damage induced by diabetic hyperglycemia.“Indena is happy to achieve the fulfillment of the monograph ‘Centella asiatica: entering a new era’, which envisages new fields of application for such an important extract – comments Giada Maramaldi, Business Development Manager-Personal Care at Indena –We’ve been studying Centella asiatica for years to meet the needs of several conditions, and we’ll keep developing new products to take advantage of this medicinal plant’s amazing potential”.A further new evidence about Centella asiatica’s application is related to the treatment of stretch marks, visible linear depressions of the skin secondary to fibroblast dysfunction, very frequently appearing during or after pregnancy. They may derive from alterations in the connective tissue secondary to weight gain and hormonal imbalances due to the fact that elastin, collagen and all their components from the mother’s skin and veins are conveyed to the developing fetal structures. A pilot study, aiming to assess the efficacy, safety and tolerability of a Centella asiatica containing cream applied in the postpartum period, shows that topical treatment with the cream may offer greater benefit in terms of improvement of the stretch marks.A final but not inconsequential aspect is how the Centella asiatica supply chain is managed sustainably. Indena is sensitive to the importance of careful and accurate control of all supply chains and to manage its business considering the environmental and social issues. As for the Centella asiatica, Indena is promoting social projects in one of the main harvesting areas of the plant, the Alaotra Mangoro region of Madagascar.
17 Apr 2026
UK pet food startup Years designs its premium meals based on a dog’s breed, life stage, and health, using wholefood recipes and clear plastic packaging.
Read more
15 Apr 2026
PepsiCo is “restaging” its biggest brands – Lay's, Tostitos, Gatorade, and Quaker – to strengthen their out-of-home positioning as consumers continue to eat outside of the home, its CEO says.
Read more
14 Apr 2026
Emissions-reduction technologies can help global manufacturers lower their environmental impact while increasing operational efficiency and making savings.
Read more
13 Apr 2026
EFSA has confirmed sucralose cannot be used in most bakery applications. So, which sweeteners can manufacturers of healthy indulgent baked goods use?
Read more
10 Apr 2026
UK company Princes Group has set a minimum 5% price increase on its products, making it the one of first major suppliers to openly raise prices due to the Iran war.
Read more
9 Apr 2026
Bold, relevant, and agile disruptor brands, such as Olly and Poppi are reshaping consumer packaged goods (CPG) and driving growth in stagnant areas – reframing everything about the categories they are showing up in, say experts.
Read more
8 Apr 2026
There are over 100 unreviewed GRAS chemicals in US food and drink products, undermining consumer trust, according to an analysis.
Read more
6 Apr 2026
Automation is helping manufacturers reduce bottlenecks but it also comes with risks. Successful brands will have clear risk management strategies.
Read more
2 Apr 2026
The partnership featured dedicated Buy Women Built in-store displays across more than 150 Tesco UK stores, showcasing female-founded brands.
Read more
27 Mar 2026
Artificial intelligence (AI) tools are adding speed, depth and innovative angles to several areas of business at General Mills and will prove invaluable in enhancing brand traction globally, its CEO says.
Read more